Sio Capital Management as of March 31, 2025
Portfolio Holdings for Sio Capital Management
Sio Capital Management holds 54 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Icon SHS (ICLR) | 10.6 | $36M | 203k | 174.99 | |
| Maximus (MMS) | 9.5 | $32M | 468k | 68.19 | |
| Merck & Co (MRK) | 7.2 | $24M | 271k | 89.76 | |
| Zimmer Holdings (ZBH) | 6.3 | $21M | 188k | 113.18 | |
| Neurocrine Biosciences (NBIX) | 6.2 | $21M | 188k | 110.60 | |
| Labcorp Holdings Com Shs (LH) | 5.8 | $20M | 84k | 232.74 | |
| Bright Minds Biosciences Com New (DRUG) | 5.5 | $18M | 508k | 36.07 | |
| Globus Med Cl A (GMED) | 4.5 | $15M | 207k | 73.20 | |
| Teleflex Incorporated (TFX) | 4.4 | $15M | 108k | 138.19 | |
| Embecta Corp Common Stock (EMBC) | 4.2 | $14M | 1.1M | 12.75 | |
| BioMarin Pharmaceutical (BMRN) | 3.0 | $10M | 141k | 70.69 | |
| Anteris Technologies Global (AVR) | 2.6 | $8.6M | 2.4M | 3.64 | |
| Haemonetics Corporation (HAE) | 2.5 | $8.5M | 134k | 63.55 | |
| Annexon (ANNX) | 2.0 | $6.6M | 3.4M | 1.93 | |
| Protara Therapeutics Com Stk (TARA) | 1.9 | $6.5M | 1.5M | 4.26 | |
| Biosante Pharmaceuticals (ANIP) | 1.7 | $5.8M | 87k | 66.95 | |
| Soleno Therapeutics Put Option (SLNO) | 1.7 | $5.6M | 78k | 71.45 | |
| Septerna (SEPN) | 1.4 | $4.6M | 789k | 5.79 | |
| Praxis Precision Medicines Inc I Com New (PRAX) | 1.3 | $4.3M | 113k | 37.87 | |
| Halyard Health (AVNS) | 1.2 | $4.1M | 286k | 14.33 | |
| Pmv Pharmaceuticals (PMVP) | 1.2 | $4.1M | 3.7M | 1.09 | |
| Tyra Biosciences (TYRA) | 1.2 | $3.9M | 417k | 9.30 | |
| Disc Medicine (IRON) | 1.1 | $3.6M | 74k | 49.64 | |
| 89bio (ETNB) | 1.1 | $3.6M | 500k | 7.27 | |
| Akero Therapeutics (AKRO) | 1.0 | $3.4M | 85k | 40.48 | |
| Vir Biotechnology (VIR) | 0.9 | $3.1M | 474k | 6.48 | |
| CryoLife (AORT) | 0.9 | $3.0M | 121k | 24.58 | |
| Ventyx Biosciences (VTYX) | 0.9 | $3.0M | 2.6M | 1.15 | |
| Proqr Therapeutics N V Shs Euro (PRQR) | 0.8 | $2.7M | 2.1M | 1.33 | |
| Vaxart Com New (VXRT) | 0.7 | $2.3M | 5.6M | 0.41 | |
| Travere Therapeutics (TVTX) | 0.6 | $2.2M | 121k | 17.92 | |
| Dianthus Therapeutics (DNTH) | 0.6 | $2.1M | 117k | 18.14 | |
| Ideaya Biosciences (IDYA) | 0.6 | $2.0M | 123k | 16.38 | |
| Savara (SVRA) | 0.6 | $2.0M | 720k | 2.77 | |
| Erasca (ERAS) | 0.6 | $1.9M | 1.4M | 1.37 | |
| Astria Therapeutics | 0.5 | $1.7M | 315k | 5.34 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.4 | $1.5M | 1.0M | 1.47 | |
| Aligos Therapeutics Com New (ALGS) | 0.4 | $1.5M | 181k | 8.25 | |
| Aquestive Therapeutics (AQST) | 0.3 | $1.1M | 392k | 2.90 | |
| Alector (ALEC) | 0.3 | $1.0M | 837k | 1.23 | |
| Enanta Pharmaceuticals (ENTA) | 0.3 | $977k | 177k | 5.52 | |
| Context Therapeutics (CNTX) | 0.2 | $813k | 1.3M | 0.61 | |
| Tela Bio (TELA) | 0.2 | $769k | 630k | 1.22 | |
| Ovid Therapeutics (OVID) | 0.2 | $696k | 2.2M | 0.31 | |
| Avalo Therapeutics Com New (AVTX) | 0.2 | $572k | 72k | 8.01 | |
| Aprea Therapeutics Com New (APRE) | 0.2 | $564k | 277k | 2.04 | |
| Foghorn Therapeutics (FHTX) | 0.1 | $444k | 122k | 3.65 | |
| Nyxoah S A SHS (NYXH) | 0.1 | $355k | 51k | 6.98 | |
| Modular Med Com New (MODD) | 0.1 | $275k | 252k | 1.09 | |
| Boundless Bio (BOLD) | 0.1 | $245k | 162k | 1.51 | |
| Nextcure | 0.0 | $62k | 130k | 0.48 | |
| Terns Pharmaceuticals (TERN) | 0.0 | $28k | 10k | 2.76 | |
| Humacyte *w Exp 08/27/202 (HUMAW) | 0.0 | $18k | 50k | 0.36 | |
| Rocket Pharmaceuticals *w Exp 09/02/202 (RCKTW) | 0.0 | $17k | 400k | 0.04 |
